You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 161 No. 11, November 2007 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Article
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Pediatrics
 •Neonatology and Infant Care
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Hypersensitivity
 •Immunology
 •Allergy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Glutamine-Enriched Enteral Nutrition in Very Low-Birth-Weight Infants

Effect on the Incidence of Allergic and Infectious Diseases in the First Year of Life

Anemone van den Berg, MD, PhD; Annelies van Zwol, MD; Henriëtte A. Moll, MD, PhD; Willem P. F. Fetter, MD, PhD; Ruurd M. van Elburg, MD, PhD

Arch Pediatr Adolesc Med. 2007;161(11):1095-1101.

Objective  To determine the effect of glutamine-enriched enteral nutrition in very low-birth-weight infants on the incidence of allergic and infectious diseases during the first year of life.

Design  Follow-up study.

Setting  Tertiary care hospital.

Participants  All surviving infants who participated in a trial of glutamine-enriched enteral nutrition in very low-birth-weight infants.

Intervention  Enteral glutamine supplementation (L-glutamine, 0.3 g/kg per day) from 3 through 30 days of life.

Main Outcome Measures  The incidence of allergic and infectious diseases during the first year of life, as assessed by means of validated questionnaires.

Results  Seventy-seven of 90 infants (86%) participated in the follow-up study. Baseline patient, maternal, and environmental characteristics did not differ between the glutamine-supplemented (n = 37) and control (n = 40) groups, except for the incidence of serious neonatal infections and child care attendance. After adjustment for confounding factors, the risk for atopic dermatitis was lower in the glutamine-supplemented group (odds ratio [OR], 0.13; 95% confidence interval [CI], 0.02-0.97). However, the incidence of bronchial hyperreactivity (OR, 0.34; 95% CI, 0.10-1.21) and infections of the upper respiratory (OR, 0.99; 95% CI, 0.35-2.79), lower respiratory (OR, 0.39; 95% CI, 0.13-1.24), and gastrointestinal (OR 1.25, 95% CI 0.23-6.86) tracts was not different between the treatment groups.

Conclusions  Glutamine-enriched enteral nutrition in very low-birth-weight infants decreased the incidence of atopic dermatitis during the first year of life but had no effect on the incidence of bronchial hyperreactivity and infectious diseases during the first year of life.


Author Affiliations: Division of Neonatology, Department of Pediatrics, VU University Medical Center, Amsterdam, the Netherlands (Drs van den Berg, van Zwol, Fetter, and van Elburg); and Department of Pediatrics, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, the Netherlands (Dr Moll).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.